Literature DB >> 28545916

Long-term success and failure with SG is predictable by 3 months: a multivariate model using simple office markers.

Austin Cottam1, Josiah Billing2, Daniel Cottam3, Peter Billing2, Samuel Cottam1, Hinali Zaveri1, Amit Surve1.   

Abstract

INTRODUCTION: Despite being the most common surgery in the United States, little is known about predicting weight loss success and failure with sleeve gastrectomy (SG). Papers that have been published are inconclusive. We decided to use multivariate analysis from 2 practices to design a model to predict weight loss outcomes using data widely available to any surgical practice at 3 months to determine weight loss outcomes at 1 year.
SETTING: Two private practices in the United States.
METHODS: A retrospective review of 613 patients from 2 bariatric institutions were included in this study. Co-morbidities and other preoperative characteristics were gathered, and %EWL was calculated for 1, 3, and 12 months. Excess weight loss (%EWL)<55% at 1 year was defined as weight loss failure. Multiple variate analysis was used to find factors that affect %EWL at 12 months.
RESULTS: Preoperative sleep apnea, preoperative diabetes, %EWL at 1 month, and %EWL at 3 months all affect %EWL at 1 year. The positive predictive value and negative predictive value of our model was 72% and 91%, respectively. Sensitivity and specificity were 71% and 91%, respectively.
CONCLUSION: One-year results of the SG can be predicted by diabetes, sleep apnea, and weight loss velocity at 3 months postoperatively. This can help surgeons direct surgical or medical interventions for patients at 3 months rather than at 1 year or beyond.
Copyright © 2017 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Obesity; Obesity surgery; Sleeve gastrectomy; Sleeve gastrectomy failure; Sleeve gastrectomy model; Weight loss model

Mesh:

Year:  2017        PMID: 28545916     DOI: 10.1016/j.soard.2017.03.016

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  6 in total

1.  An Analysis of Mid-Term Complications, Weight Loss, and Type 2 Diabetes Resolution of Stomach Intestinal Pylorus-Sparing Surgery (SIPS) Versus Roux-En-Y Gastric Bypass (RYGB) with Three-Year Follow-Up.

Authors:  Austin Cottam; Daniel Cottam; Hinali Zaveri; Samuel Cottam; Amit Surve; Walter Medlin; Christina Richards
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

2.  The influence of obstructive sleep apnea syndrome on anthropometric parameters at 12 months after laparoscopic sleeve gastrectomy.

Authors:  Laura Mihalache; Dimitrie Siriopol; Lidia Iuliana Arhire; Sergiu Pădureanu; Cristina Preda; Daniela Boișteanu; Dragoș Scripcariu; Silvia Cusai; Adrian Covic
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

3.  Early Postoperative Weight Loss Predicts Weight Loss up to 5 Years After Roux-En-Y Gastric Bypass, Banded Roux-En-Y Gastric Bypass, and Sleeve Gastrectomy.

Authors:  Onno M Tettero; Valerie M Monpellier; Ignace M C Janssen; Ingrid H M Steenhuis; Maartje M van Stralen
Journal:  Obes Surg       Date:  2022-07-16       Impact factor: 3.479

4.  Sleeve Gastrectomy Weight Loss and the Preoperative and Postoperative Predictors: a Systematic Review.

Authors:  Samuel Cottam; Daniel Cottam; Austin Cottam
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

5.  The Use of Predictive Markers for the Development of a Model to Predict Weight Loss Following Vertical Sleeve Gastrectomy.

Authors:  Samuel Cottam; Daniel Cottam; Austin Cottam; Hinali Zaveri; Amit Surve; Christina Richards
Journal:  Obes Surg       Date:  2018-12       Impact factor: 4.129

6.  Check point to get adequate weight loss within 6-months after laparoscopic sleeve gastrectomy for morbid obesity in Asian population.

Authors:  Ming-Hsien Lee; Jian-Han Chen; Chung-Yen Chen; Cheng-Hung Lee; Hui-Ming Lee; Wen-Yao Yin; Wei-Leng Chin
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.